Teva Pharmaceutical Industries and Takeda Pharmaceutical Co. have entered into a definitive agreement to establish a new business venture to meet a range needs for generics in Japan. Japan is among the fastest growing generics markets in the world, driven by social requirements for stable supply of affordable high quality medicines and the Japanese government’s policy of reduction of healthcare expenditures. Takeda’s strong distribution presence in Japan will combine with Teva’s supply cha...